These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8526048)

  • 1. Epidermal Langerhans cell migration: signals and mechanisms.
    Cumberbatch M; Fielding I; Kimber I
    Adv Exp Med Biol; 1995; 378():173-5. PubMed ID: 8526048
    [No Abstract]   [Full Text] [Related]  

  • 2. Stimulation of Langerhans cell migration in mice by tumour necrosis factor alpha and interleukin 1 beta.
    Cumberbatch M; Dearman RJ; Kimber I
    Adv Exp Med Biol; 1997; 417():121-4. PubMed ID: 9286348
    [No Abstract]   [Full Text] [Related]  

  • 3. alpha 6 integrins are required for Langerhans cell migration.
    Price AA; Cumberbatch M; Kimber I; Ager A
    Adv Exp Med Biol; 1997; 417():129-32. PubMed ID: 9286350
    [No Abstract]   [Full Text] [Related]  

  • 4. Interleukin 1 beta and the stimulation of Langerhans cell migration: comparisons with tumour necrosis factor alpha.
    Cumberbatch M; Dearman RJ; Kimber I
    Arch Dermatol Res; 1997 Apr; 289(5):277-84. PubMed ID: 9164638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Langerhans cells require signals from both tumour necrosis factor alpha and interleukin 1 beta for migration.
    Cumberbatch M; Dearman RJ; Kimber I
    Adv Exp Med Biol; 1997; 417():125-8. PubMed ID: 9286349
    [No Abstract]   [Full Text] [Related]  

  • 6. Langerhans cell migration in mice requires intact type I interleukin 1 receptor (IL-1RI) function.
    Cumberbatch M; Dearman RJ; Kimber I
    Arch Dermatol Res; 1999 Jun; 291(6):357-61. PubMed ID: 10421063
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction by tumour necrosis factor alpha of dose-related changes in Langerhans cell frequency in mice.
    Cumberbatch M; Dearman RJ; Kimber I
    Arch Dermatol Res; 1999; 291(7-8):453-8. PubMed ID: 10482017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by dexamethasone of Langerhans cell migration: influence of epidermal cytokine signals.
    Cumberbatch M; Dearman RJ; Kimber I
    Immunopharmacology; 1999 Apr; 41(3):235-43. PubMed ID: 10428652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation by lactoferrin of epidermal Langerhans cell migration.
    Kimber I; Cumberbatch M; Dearman RJ; Ward P; Headon DR; Conneely OM
    Adv Exp Med Biol; 1998; 443():251-5. PubMed ID: 9781366
    [No Abstract]   [Full Text] [Related]  

  • 10. Vascular endothelial growth factor (VEGF) induces human Langerhans cell migration.
    Staquet MJ; Godefroy S; Jacquet C; Viac J; Schmitt D
    Arch Dermatol Res; 2001 Feb; 293(1-2):26-8. PubMed ID: 11289578
    [No Abstract]   [Full Text] [Related]  

  • 11. Roles for IL-1 and TNFalpha in dynamic behavioral responses of Langerhans cells to topical hapten application.
    Nishibu A; Ward BR; Boes M; Takashima A
    J Dermatol Sci; 2007 Jan; 45(1):23-30. PubMed ID: 17123788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour necrosis factor-alpha induces Langerhans cell migration in humans.
    Cumberbatch M; Griffiths CE; Tucker SC; Dearman RJ; Kimber I
    Br J Dermatol; 1999 Aug; 141(2):192-200. PubMed ID: 10468787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Langerhans cells in CD44-deficient mice emigrate from the epidermis but fail to reach the lymph nodes after hapten application.
    Mummert DI; Takashima A; Mummert ME
    J Invest Dermatol; 2004 Mar; 122(3):846-7. PubMed ID: 15086576
    [No Abstract]   [Full Text] [Related]  

  • 14. Migration of interleukin-6 producing Langerhans cells to draining lymph nodes following skin sensitization.
    Cumberbatch M; Hope JC; Dearman RJ; Hopkins SJ; Kimber I
    Adv Exp Med Biol; 1995; 378():531-3. PubMed ID: 8526135
    [No Abstract]   [Full Text] [Related]  

  • 15. Interleukin-16 supports the migration of Langerhans cells, partly in a CD4-independent way.
    Stoitzner P; Ratzinger G; Koch F; Janke K; Schöller T; Kaser A; Tilg H; Cruikshank WW; Fritsch P; Romani N
    J Invest Dermatol; 2001 May; 116(5):641-9. PubMed ID: 11348450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-17 and interleukin-23 regulate Langerhans cell migration.
    Eaton LH; Dearman RJ; Kimber I; Griffiths CE
    Br J Dermatol; 2016 Sep; 175(3):622-4. PubMed ID: 26972796
    [No Abstract]   [Full Text] [Related]  

  • 17. Dermal tumour necrosis factor-alpha induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans' cell migration.
    Cumberbatch M; Kimber I
    Immunology; 1992 Feb; 75(2):257-63. PubMed ID: 1551688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Langerhans cells require signals from both tumour necrosis factor-alpha and interleukin-1 beta for migration.
    Cumberbatch M; Dearman RJ; Kimber I
    Immunology; 1997 Nov; 92(3):388-95. PubMed ID: 9486113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adhesion and migration of epidermal dendritic cells].
    Staquet MJ
    Pathol Biol (Paris); 1995 Dec; 43(10):858-62. PubMed ID: 8786890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1beta but not tumor necrosis factor is involved in West Nile virus-induced Langerhans cell migration from the skin in C57BL/6 mice.
    Byrne SN; Halliday GM; Johnston LJ; King NJ
    J Invest Dermatol; 2001 Sep; 117(3):702-9. PubMed ID: 11564180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.